News Anatara Lifesciences Ltd

Equities

ANR

AU000000ANR0

Market Closed - Australian S.E. Other stock markets 01:48:01 2024-06-07 am EDT			5-day change	1st Jan Change
0.04 ^AUD	-9.09%		-14.89%	+81.82%

May. 01	Anatara Lifesciences Raises AU$1 Million via Shares Placement; Shares Decline 6%	MT
Apr. 09	Anatara Lifesciences Begins Recruitment for Irritable Bowel Syndrome Stage Two Trial	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Anatara Lifesciences Raises AU$1 Million via Shares Placement; Shares Decline 6%	Apr. 30	MT
Anatara Lifesciences Begins Recruitment for Irritable Bowel Syndrome Stage Two Trial	Apr. 08	MT
Anatara Lifesciences Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 27	CI
Anatara Lifesciences Raised Nealy AU$960,000 Via Entitlement Offer	Dec. 08	MT
Anatara Lifesciences Limited Webinar on the Company's Stage 1 Irritable Bowel Syndrome	23-10-17	AW
Anatara Lifesciences Limited (ASX:ANR) Webinar on the Company's Stage 1 Irritable Bowel Syndrome	23-10-17	AQ
Anatara Lifesciences Ltd Announces Board Changes	23-10-01	CI
Anatara Lifesciences to Proceed to Stage II of IBS Drug Trial	23-09-28	MT
Anatara Lifesciences Finalizes Patients for Irritable Bowel Syndrome Clinical Trial Stage One	23-08-30	MT
Anatara Lifesciences Ltd Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-23	CI
Anatara Lifesciences Receives R&D Tax Rebate; Shares Up 3%	23-08-14	MT
Anatara Lifesciences Ltd Announces Registered Office Change	23-04-19	CI
Anatara Lifesciences Provides Update on the Gastrointestinal Reprogramming(Garp) Trial for IBS	23-03-09	CI
Anatara Lifesciences Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23	CI
Anatara Lifesciences Ltd Announces board Changes	22-12-06	CI
Anatara Lifesciences Raising Funds for Patient Trial, Future Project Acquisitions	22-10-21	MT
Anatara Lifesciences Receives More than $310,000 R&D Tax Rebate	22-10-04	MT
CSIRO Halts Psychological Functioning Trial for Dietary Supplement	22-10-03	MT
Anatara Lifesciences Limited Provides Updates on 3FDC Clinical Trial	22-10-02	CI
Anatara Lifesciences Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Anatara Lifesciences Ltd

Equities

ANR

AU000000ANR0

Summary

Filters